Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II study
2021 · European Journal of Cancer · 48 citations
https://doi.org/10.1016/j.ejca.2021.07.021
Y
Yuqin Song
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
135
Papers
899
Citations
17
h-index
27
i10-index
Yuqin Song is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & CAR-T cell therapy research. The author has an h-index of 17, co-authored 115 publications.
ORCID: 0000-0002-5118-0625Papers by this author
worksSafety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial
2018 · Blood · 38 citations
https://doi.org/10.1182/blood-2018-99-117956
Patient safety culture in Peking University Cancer Hospital in China: baseline assessment and comparative analysis for quality improvement
2019 · BMC Health Services Research · 23 citations
https://doi.org/10.1186/s12913-019-4837-z
Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial
2024 · Haematologica · 3 citations
https://doi.org/10.3324/haematol.2024.284973
EZH2 inhibitor SHR2554 enhances the anti-tumor efficacy of HDAC inhibitor Chidamide through STAT1 in T-cell lymphoma
2025 · Cell Death and Disease · 2 citations
https://doi.org/10.1038/s41419-025-07775-x
Rankl expression predicts poor prognosis in gastric cancer patients: results from a retrospective and single-center analysis
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5792586
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat